Some tasty arithmetic ... Total = 164,204 units
Post# of 7791
(Total Views: 557)
Posted On: 09/13/2020 10:47:47 AM
Some tasty arithmetic ...
Total = 164,204 units (for 3rd qtr.)
I don't know what the profit amount is per unit so I will guess it to be $5 per unit. Taking into account our NOLs this will result a little over $820,000 to the bottom line for the 3rd qtr financials. This will be announced in mid October, or thereabouts. Wouldn't this make us profitable?
In q4 '20 and q1 '21 is when the fun begins. According to the Chairman's letter we have, already, 5 signed contracts with a probable sixth. No way would our esteemed chairman with the standing of Dr. Staelin misrepresent a situation so crucial and fundamental to the company's success as this, contractual agreements. Remember, there was no 'Safe Harbor Statement'. He would be risking everything he has, everything he has achieved, and his personal freedom, as well. Not happening. He's got this.
I will assume he is correct about the sixth contract. That means we can reasonably expect six press releases if they have a pr for each contract. That way each company gets the full attention in each pr and it maximazes the share price increase as well as giving us much needed exposure. The other aspect of the COB letter, besides informing us shareholders, was to signal the fencesitters - if we do not have you under contract your competitors must assuredly are, call us.
The most recent news we have, thanks to Swordfish, is now << Mundipharma Australia adds a new Actipatch Retailer specializing in Aged Care Facilities >>. This includes Adelaide, Melbourne, Canberra, Sydney, Brisbane, Cairns, and Perth - ie. - all major cities in the country. Quote: " ... to ensure provision of a uniform system and standardised services to all facilities across Australia , particularly important for larger organisations ... ".
Besides the FDA full body clearance, there is one more item we are aiming for and, of course, that is insurance coverage. "uniform system and standardised services" Very easy to fold that into an insurance program.
From my post # 2584. I also sent (on advice from graveldrive, thx) to CEO K Whelan, who responded that it was passed along to the appropiate contractors and relevant staff (post # 2589). With what we have done so far, the share price will reflect that in due time, within six months is my timeframe. Should we get insurance coverage along the way over those six months, than take the share price and attach a turbo-charged nitroglycerin booster to make it simulate a dragster coming off the starting line. Explosive growth. Full FDA clearance is fantastic as it has formed the basis of everything we have so far. Insurance coverage is essentially the holy grail of 'Standard-of-Care'.
https://www.massdevice.com/cms-agrees-to-cove...l-devices/
MCIT-covered devices would also have to fit Medicare statutory definitions of “Reasonable and Necessary” for treating patients. To that end, the proposed rule would refine the definitions of “reasonable and necessary.” Among the requirements, devices would need to be considered:
• Safe and effective.
• Not experimental or investigational.
• Appropriate for Medicare patients, including the duration and
frequency that is considered appropriate and whether it is
covered by commercial insurers.
Don't misunderstand me. I think we have our 'finger on the pulse' in re: to getting us onto insurance schedules than BIEL management wants to let on about. Dr. Staelin's appointment to the board carries with it a recognition that we have, indeed, arrived on the scene and we are 'making it happen' in a serious and focussed manner. I sent the email to CEO Whelan more to make me feel good as I believe she knew all about it beforehand. However, graveldrive was right, better safe than sorry.
brain droppings (salute to Geo. Carlin) - take care - WBeacham
Total = 164,204 units (for 3rd qtr.)
I don't know what the profit amount is per unit so I will guess it to be $5 per unit. Taking into account our NOLs this will result a little over $820,000 to the bottom line for the 3rd qtr financials. This will be announced in mid October, or thereabouts. Wouldn't this make us profitable?
In q4 '20 and q1 '21 is when the fun begins. According to the Chairman's letter we have, already, 5 signed contracts with a probable sixth. No way would our esteemed chairman with the standing of Dr. Staelin misrepresent a situation so crucial and fundamental to the company's success as this, contractual agreements. Remember, there was no 'Safe Harbor Statement'. He would be risking everything he has, everything he has achieved, and his personal freedom, as well. Not happening. He's got this.
I will assume he is correct about the sixth contract. That means we can reasonably expect six press releases if they have a pr for each contract. That way each company gets the full attention in each pr and it maximazes the share price increase as well as giving us much needed exposure. The other aspect of the COB letter, besides informing us shareholders, was to signal the fencesitters - if we do not have you under contract your competitors must assuredly are, call us.
The most recent news we have, thanks to Swordfish, is now << Mundipharma Australia adds a new Actipatch Retailer specializing in Aged Care Facilities >>. This includes Adelaide, Melbourne, Canberra, Sydney, Brisbane, Cairns, and Perth - ie. - all major cities in the country. Quote: " ... to ensure provision of a uniform system and standardised services to all facilities across Australia , particularly important for larger organisations ... ".
Besides the FDA full body clearance, there is one more item we are aiming for and, of course, that is insurance coverage. "uniform system and standardised services" Very easy to fold that into an insurance program.
From my post # 2584. I also sent (on advice from graveldrive, thx) to CEO K Whelan, who responded that it was passed along to the appropiate contractors and relevant staff (post # 2589). With what we have done so far, the share price will reflect that in due time, within six months is my timeframe. Should we get insurance coverage along the way over those six months, than take the share price and attach a turbo-charged nitroglycerin booster to make it simulate a dragster coming off the starting line. Explosive growth. Full FDA clearance is fantastic as it has formed the basis of everything we have so far. Insurance coverage is essentially the holy grail of 'Standard-of-Care'.
https://www.massdevice.com/cms-agrees-to-cove...l-devices/
MCIT-covered devices would also have to fit Medicare statutory definitions of “Reasonable and Necessary” for treating patients. To that end, the proposed rule would refine the definitions of “reasonable and necessary.” Among the requirements, devices would need to be considered:
• Safe and effective.
• Not experimental or investigational.
• Appropriate for Medicare patients, including the duration and
frequency that is considered appropriate and whether it is
covered by commercial insurers.
Don't misunderstand me. I think we have our 'finger on the pulse' in re: to getting us onto insurance schedules than BIEL management wants to let on about. Dr. Staelin's appointment to the board carries with it a recognition that we have, indeed, arrived on the scene and we are 'making it happen' in a serious and focussed manner. I sent the email to CEO Whelan more to make me feel good as I believe she knew all about it beforehand. However, graveldrive was right, better safe than sorry.
brain droppings (salute to Geo. Carlin) - take care - WBeacham
(4)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼